Mode
Text Size
Log in / Sign up
N/A Completed N=68

A Feasibility Study Followed By A Randomized Phase II Study Of Yoga For Radiation Therapy Side Effects In Prostate Cancer

Source: ClinicalTrials.gov NCT02135653 ↗
Enrolled (actual)
68
Serious AEs
0.0%
Results posted
May 2021
Primary outcomePrimary: Adverse Events — 0; 0 Adverse Events

Summary

This study will ascertain the feasibility and effect of Eischens yoga interventions on radiation related fatigue, sexual dysfunction and urinary incontinence in stage I /II prostate cancer patients undergoing radiotherapy with photons and/or protons without prostatectomy. Subjects must be smoke free and have not taken regular yoga classes 6 months prior to enrollment. Subjects will participate in twice weekly yoga sessions for 8 weeks and complete 4 quality of life forms 5 times during study.

Outcome Measures

OutcomeResultp-value
PRIMARY
Adverse Events
0; 0
SECONDARY
Brief Fatigue Inventory Score
12.2; 27.4
SECONDARY
Functional Assessment of Cancer Therapy: Physical Well-Being Score
24.9; 24.3
SECONDARY
Functional Assessment of Cancer Therapy: Social Well-Being Score
23.5; 21.4
SECONDARY
Functional Assessment of Cancer Therapy: Emotional Well-Being Score
20.1; 21.0
SECONDARY
Functional Assessment of Cancer Therapy: Functional Well-Being
22.5; 21.4
SECONDARY
International Index of Erectile Function Score
22.5; 21.4
SECONDARY
International Prostate Symptom Score
10.8; 15

Eligibility Criteria

Inclusion Criteria

Patients

  • Prostate cancer patients undergoing active radiation therapy (external beam radiation with photons and/ or protons). Prior or concurrent androgen deprivation therapy is permitted.
  • Patients of age >18 years, and all races will be included in the study.
  • Patients must have an ECOG Performance Score ≤ 1
  • All patients must sign an informed consent form

Caregivers

  • Subject is age >18 years
  • Subject is English-speaking
  • Subject must sign an informed consent form

Exclusion Criteria

Patients

  • Patients with medical restrictions that may interfere with or prevent them from taking part in the yoga interventions per their physician orders as evaluated by ECOG Performance Status score.
  • Active, regular cigarette smokers, such that smoking may interfere with relaxation and breathing modalities of the yoga interventions. (Smokers that have been smoke-free for 6 months may be included)
  • Patients who currently practice or have recently practiced yoga (taken a yoga class on a regular basis in the last 6 months).
  • Patients who are undergoing chemotherapy for any reason
  • Patients with evidence of metastatic disease

Caregivers

  • Subjects that are unwilling or unable to provide informed consent
  • Subjects with medical restrictions that may interfere with or prevent them from taking part in the yoga interventions
  • Active, regular cigarette smokers, such that smoking may interfere with relaxation and breathing modalities of the yoga interventions. (Smokers that have been smoke-free for 6 months may be included)
  • Patients who currently practice or have recently practiced yoga (taken a yoga class on a regular basis in the last 6 months).
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT02135653). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.

Back to search